Skip to main content

Jeff Lagasse

By Jeff Lagasse | 04:11 pm | January 26, 2022
AGS believes it's premature for CMS to issue a coverage determination for other antibodies in the pipeline that don't yet have FDA approval.
By Jeff Lagasse | 11:07 am | January 26, 2022
The agency is not, however, withdrawing the emergency temporary standard as a proposed rule, saying it will work on a permanent standard.
By Jeff Lagasse | 04:12 pm | January 25, 2022
The senators framed the widespread availability of free tests - along with vaccination - as a means of eventually ending the pandemic.
By Jeff Lagasse | 12:38 pm | January 25, 2022
Uncertainty over when the waiver will end may create barriers to entry for new participants, the groups say.
By Jeff Lagasse | 04:26 pm | January 24, 2022
The organizations touted the potential benefits, including improved patient communications and reduced readmission rates.
By Jeff Lagasse | 12:39 pm | January 24, 2022
The task force’s primary goal is to protect and bolster sexual and reproductive health, including the right to safe and legal abortion care.
By Jeff Lagasse | 04:42 pm | January 20, 2022
The lack of adequate safeguards, highlighted by employee complaints, were found primarily in the Children's Hospital at Montefiore.
By Jeff Lagasse | 12:26 pm | January 20, 2022
MarinHealth hopes the relationship will equip it with the necessary tools and resources to improve business processes and enhance infrastructure.
By Jeff Lagasse | 04:27 pm | January 19, 2022
The company's full-year revenue grew more than $30 billion, or 11.8%, to $287.6 billion year-over-year.
By Jeff Lagasse | 01:08 pm | January 19, 2022
The policy is set to begin in March, at which point new access restrictions will be placed on all drugs other than the company's IMiD offerings.